Oct
2026
Fiera Milano, Italy
Visit us
stand 20H22, Finished Dosage & Formulation
Zone

Hangzhou Jiuyuan Genetic Biopharmaceutical Co.,Ltd

Exhibitor at CPHI Milan 2026
About Us

We are a leading biopharmaceutical company firstly developed the following products in China: rhG-CSF (filgrastim), Pegfilgrastim, Liraglutide(recombinant),Enoxaparin sodium, Fulvestrant, Interleukin-11, Palonosetron Hydrochloride, rhBMP-2 , Fosaprepitant dimeglumine. Our product pipeline include: Semaglutide (recombinant), Recombinant Hyaluronidase,  Avatrombopag maleate, Bone repair material with rhBMP-2 - Bone repair, Romosozumab,Daratumumab, Emicizumab, Amylin analog, SIRPα- specific monoclonal antibody.

  • Country/Region:
    China
  • On CPHI since:
    2015
  • Certificates:
    5
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Contact info
Event information
CPHI Milan 2026
  • 6 Oct 2026 - 8 Oct 2026
  • Fiera Milano, Italy
  • Visit us at stand 20H22, Finished Dosage & Formulation

Products Featured at CPHI Milan 2026